Download this file
Download this file Download this file
Irish Haematology Society: Summary of recommendations • Develop JACIE/cGMP standard cryobiology laboratories at IBTS Dublin, Cork • Transfer of existing hospital-based processing at St. James’s to IBTS facility. • Enhancement of existing facilities at St. Vincent’s Hospital, Mater and Galway to cGMP standard • Discussions with Crumlin OLHSC re optimal development of paediatric stem cell laboratory • Each laboratory to provide support for products collected and/reinfused at one or multiple approved clinical transplant sites/units. • Provision of consultant sessional commitment for each designated facility, as outlined
Implementation in Ireland • DOHC Steering group • Health Service Executive • Resource implication
- Page 1 and 2: Haematopoietic stem cells: implicat
- Page 3 and 4: Stem cells live in bone marrow nich
- Page 5 and 6: What do stem cells look like
- Page 7 and 8: White cell colony CFU-GM
- Page 9 and 10: Stem cell transplants in Europe HSC
- Page 11 and 12: HSCT in Europe 1990-2000 Main indic
- Page 13 and 14: Adult BMT Programme: St James’s H
- Page 15 and 16: Survival of patients with acute mye
- Page 17 and 18: Autologous stem cell harvests/cryop
- Page 19 and 20: The Responsible Person The person d
- Page 21 and 22: Serious adverse events/reactions 1.
- Page 23 and 24: Core principle: Progenitor cell pro
- Page 25 and 26: Laboratory personnel Minimum staffi
- Page 28 and 29: JACIE standards and programme
Irish Haematology Society:<br />
Summary of recommendations<br />
• Develop JACIE/cGMP standard cryobiology laboratories at IBTS<br />
Dublin, Cork<br />
• Transfer of existing hospital-based processing at St. James’s to<br />
IBTS facility.<br />
• Enhancement of existing facilities at St. Vincent’s Hospital, Mater<br />
and Galway to cGMP standard<br />
• Discussions with Crumlin OLHSC re optimal development of<br />
paediatric stem cell laboratory<br />
• Each laboratory to provide support for products collected and/reinfused<br />
at one or multiple approved clinical transplant sites/units.<br />
• Provision of consultant sessional commitment for each designated<br />
facility, as outlined